State of Alaska Department of Revenue’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-8,581
| Closed | -$90K | – | 1638 |
|
|
2023
Q1 | $90K | Sell |
8,581
-144
| -2% | -$1.51K | ﹤0.01% | 1625 |
|
|
2022
Q4 | $295K | Buy |
8,725
+75
| +0.9% | +$2.54K | ﹤0.01% | 1544 |
|
|
2022
Q3 | $415K | Sell |
8,650
-744
| -8% | -$35.7K | 0.01% | 1399 |
|
|
2022
Q2 | $535K | Buy |
9,394
+835
| +10% | +$47.6K | 0.01% | 1328 |
|
|
2022
Q1 | $691K | Sell |
8,559
-152
| -2% | -$12.3K | 0.01% | 1233 |
|
|
2021
Q4 | $1.77M | Buy |
8,711
+6,793
| +354% | +$1.38M | 0.02% | 775 |
|
|
2021
Q3 | $516K | Buy |
1,918
+42
| +2% | +$11.3K | 0.01% | 1447 |
|
|
2021
Q2 | $482K | Sell |
1,876
-24
| -1% | -$6.17K | ﹤0.01% | 1462 |
|
|
2021
Q1 | $570K | Sell |
1,900
-40
| -2% | -$12K | 0.01% | 1362 |
|
|
2020
Q4 | $494K | Sell |
1,940
-95
| -5% | -$24.2K | 0.01% | 1362 |
|
|
2020
Q3 | $506K | Sell |
2,035
-77
| -4% | -$19.1K | 0.01% | 1234 |
|
|
2020
Q2 | $733K | Buy |
2,112
+94
| +5% | +$32.6K | 0.01% | 1052 |
|
|
2020
Q1 | $540K | Buy |
2,018
+90
| +5% | +$24.1K | 0.01% | 1067 |
|
|
2019
Q4 | $624K | Sell |
1,928
-151
| -7% | -$48.9K | 0.01% | 1198 |
|
|
2019
Q3 | $567K | Sell |
2,079
-683
| -25% | -$186K | 0.01% | 1206 |
|
|
2019
Q2 | $1.47M | Sell |
2,762
-579
| -17% | -$309K | 0.02% | 612 |
|
|
2019
Q1 | $1.68M | Buy |
3,341
+116
| +4% | +$58.4K | 0.03% | 559 |
|
|
2018
Q4 | $1.59M | Buy |
3,225
+182
| +6% | +$89.7K | 0.03% | 544 |
|
|
2018
Q3 | $2.78M | Buy |
3,043
+179
| +6% | +$164K | 0.05% | 446 |
|
|
2018
Q2 | $2.1M | Buy |
2,864
+2,409
| +529% | +$1.76M | 0.04% | 523 |
|
|
2018
Q1 | $724K | Sell |
455
-1,637
| -78% | -$2.6M | 0.02% | 772 |
|
|
2017
Q4 | $1.87M | Buy |
2,092
+26
| +1% | +$23.3K | 0.04% | 489 |
|
|
2017
Q3 | $743K | Buy |
2,066
+24
| +1% | +$8.63K | 0.04% | 570 |
|
|
2017
Q2 | $598K | Buy |
2,042
+905
| +80% | +$265K | 0.04% | 347 |
|
|
2017
Q1 | $400K | Buy |
1,137
+31
| +3% | +$10.9K | 0.03% | 417 |
|
|
2016
Q4 | $203K | Buy |
+1,106
| New | +$203K | 0.02% | 431 |
|